Skip to content
Clinical Trials – home
Verifiedinfo

BKS Research Kft.

Hungary Balassi Balint Ut 16, 3000 Hatvan, Hungary

  • 10 trials recruiting
  • Arteriosclerosis · Cardiac failure · Cardiovascular disorder
  • Adults and children

About Specializations

BKS Research Kft. in Hatvan, Hungary specialises in clinical trials of conditions such as Arteriosclerosis, Cardiac failure, Cardiovascular disorder, Hypertension, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Diseases and Metabolic Research

At BKS Research Kft. in Hatvan, Hungary, a major share of the clinical research focuses on cardiovascular disease and nutritional and metabolic disorders. The studies are designed to assess new approaches for reducing heart-related events, improving heart failure care, and supporting better control of conditions linked to obesity, type 2 diabetes, and hypertension.

  • Testing new treatments aimed at lowering the risk of cardiovascular events in people with established or high-risk heart disease
  • Evaluating therapies for heart failure, including forms with preserved and reduced pumping function
  • Studying treatment options for obesity, overweight, and related cardiometabolic conditions

This research area combines prevention and treatment goals, with a strong emphasis on improving outcomes for patients at risk of serious heart and metabolic complications.

Respiratory Tract Diseases

The site also supports studies in respiratory medicine, especially for chronic obstructive pulmonary disease, asthma, and bronchiectasis. These trials are centered on easing breathing problems, reducing flare-ups, and comparing inhaled therapies to find more effective and better-tolerated options.

  • Assessing treatments for COPD to improve lung function and reduce exacerbations
  • Comparing inhaled therapies for asthma control and airway safety
  • Investigating options for bronchiectasis to help lower pulmonary worsening over time

Overall, the respiratory portfolio is aimed at improving symptom control and long-term disease management in common and chronic lung diseases.

Digestive System Diseases and Inflammatory Conditions

Research at this facility includes gastroenterology, with trials in ulcerative colitis that explore how well new treatments can induce remission and relieve intestinal inflammation. The goal is to improve day-to-day disease control for patients living with active bowel disease.

  • Evaluating therapies for ulcerative colitis to achieve clinical remission
  • Focusing on better control of digestive tract inflammation and related symptoms
  • Supporting studies that aim to improve treatment effectiveness in chronic intestinal disease

This area reflects a practical focus on symptom relief, remission, and improved quality of life for people with inflammatory bowel disease.

Nervous System Diseases and Pain-Related Research

The site is involved in studies of diabetic sensorimotor polyneuropathy, a nerve complication associated with diabetes that can cause pain, numbness, and loss of sensation. These trials are intended to assess whether new combined treatments can better ease symptoms and support nerve-related function.

  • Investigating symptom relief in diabetic neuropathy
  • Comparing treatment strategies for nerve pain and sensory problems
  • Exploring improved care for diabetes-related neurological complications

This research area highlights the site’s interest in finding more effective ways to manage chronic neuropathic symptoms linked to metabolic disease.

Skin and Connective Tissue Diseases

Another important field at BKS Research Kft. is the study of chronic venous ulcers, where the focus is on helping stubborn wounds heal and improving local treatment options. These trials are designed to evaluate whether new therapies can support wound closure in patients whose ulcers have not responded well to standard care.

  • Testing treatments for non-healing venous leg ulcers
  • Assessing wound closure and treatment safety
  • Exploring better care for chronic skin and tissue damage

The work in this area is focused on practical healing outcomes and improving options for patients with difficult-to-treat wounds.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Balassi Balint Ut 163000 HatvanHungary
Recruiting now
10 trials
Conditions studied
18
Partner status
Verified

More sites in HatvanHungary

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

26 clinical trials

Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.

Bronchiectasis

Recruiting
Investigational
Countries:HungaryHungary
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Bi 1291583
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Sponsor:Pfizer Inc.
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.

Cardiac failure

Recruiting
Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Placebo
  • Sponsor:Chiesi Farmaceutici S.p.A.
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Tezepelumab
  • Sponsor:AstraZeneca AB

Arteriosclerosis

Not yet recruiting
Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Crd-4730
  • Sponsor:Cardurion Pharmaceuticals Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.